Lipegfilgrastim
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13200 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 56 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | severe nonproliferative diabetic retinopathy | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | Glanzmann thrombasthenia | KG + DL |
| 5 | diabetic retinopathy | KG + DL |
| 6 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 7 | thrombocytopenia due to immune destruction | KG + DL |
| 8 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 9 | Scott syndrome | KG + DL |
| 10 | drug-induced osteoporosis | KG + DL |
| 11 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 12 | neonatal thrombocytopenia | KG + DL |
| 13 | HER2 positive breast carcinoma | KG + DL |
| 14 | dermatitis | KG + DL |
| 15 | autoimmune thrombocytopenic | KG + DL |
| 16 | diabetic cataract | KG + DL |
| 17 | platelet-type bleeding disorder | KG + DL |
| 18 | seborrheic dermatitis | KG + DL |
| 19 | acrodermatitis chronica atrophicans | KG + DL |
| 20 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 21 | neurolymphomatosis | KG + DL |
| 22 | breast tumor luminal A or B | KG + DL |
| 23 | normal breast-like subtype of breast carcinoma | KG + DL |
| 24 | progesterone-receptor positive breast cancer | KG + DL |
| 25 | neonatal dermatomyositis | KG + DL |
| 26 | progesterone-receptor negative breast cancer | KG + DL |
| 27 | plasmacytoma | KG + DL |
| 28 | autosomal thrombocytopenia with normal platelets | KG + DL |
| 29 | hydroa vacciniforme, familial | KG + DL |
| 30 | acne keloid | KG + DL |
| 31 | amyopathic dermatomyositis | KG + DL |
| 32 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 33 | senile cataract | KG + DL |
| 34 | cortical cataract | KG + DL |
| 35 | nuclear senile cataract | KG + DL |
| 36 | autosomal dominant macrothrombocytopenia | KG + DL |
| 37 | filariasis | KG + DL |
| 38 | indolent plasma cell myeloma | KG + DL |
| 39 | cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder | KG + DL |
| 40 | syndromic constitutional thrombocytopenia | KG + DL |
| 41 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 42 | pityriasis simplex | KG + DL |
| 43 | plasma cell myeloma | KG + DL |
| 44 | familial thrombomodulin anomalies | KG + DL |
| 45 | flood factor deficiency | KG + DL |
| 46 | tetanic cataract | KG + DL |
| 47 | immature cataract | KG + DL |
| 48 | mature cataract | KG + DL |
| 49 | diabetes mellitus type 2 associated cataract | KG + DL |
| 50 | craniostenosis cataract | KG + DL |
(Showing top 50 of 56 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.